(S)-Enzaplatovir (Synonyms: (S)-BTA-C585) |
| カタログ番号GC62750 |
(S)-エンザプラトビル ((S)-BTA-C585) は、エンザプラトビルの S-エナンチオマーです。 (S)-エンザプラトビルは、呼吸器合胞体ウイルス (RSV) に対して 56 nM の EC50 で抗ウイルス活性を示します (特許 WO2011094823A1 化合物 77)。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1323077-88-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77)[1].
[1]. Jeffrey Peter Mitchell, et al. Compounds for treating respiratory syncytial virus infections. WO2011094823A1
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *